Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


07.10.2019

1 Aktuelle Urol
1 Arch Med Sci
1 Biofactors
2 Biomed Pharmacother
3 BJU Int
1 BMJ Open
1 Br J Radiol
1 Can J Infect Dis Med Microbiol
1 Cancer Epidemiol
1 Cancer Manag Res
1 Cancer Med
1 Chin Med J (Engl)
1 Clin Exp Med
1 Curr Urol
1 Dis Markers
1 Epidemiology
1 Eur J Cancer Prev
5 Eur Urol
1 Eur Urol Focus
1 Genes Genomics
1 J Cell Mol Med
1 J Clin Med
1 Mol Genet Genomic Med
1 Nat Rev Urol
2 Onco Targets Ther
1 Pathol Res Pract
1 Sci Adv
1 Urol Int
1 Urol Oncol
1 Urologiia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aktuelle Urol

  1. ALBARGHOUTH MH, Hamza A
    [The impact of using intraoperative photodynamic diagnosis on the prognosis of bladder cancer].
    Aktuelle Urol. 2019 Sep 26. doi: 10.1055/a-1007-8497.
    PubMed     Text format     Abstract available


    Arch Med Sci

  2. FU W, Wu X, Yang Z, Mi H, et al
    The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.
    Arch Med Sci. 2019;15:1154-1162.
    PubMed     Text format     Abstract available


    Biofactors

  3. LI D, Jiao W, Liang Z, Wang L, et al
    Variation in energy metabolism arising from the effect of the tumor microenvironment on cell biological behaviors of bladder cancer cells and endothelial cells.
    Biofactors. 2019 Oct 3. doi: 10.1002/biof.1568.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  4. YANG D, Ma Y, Zhao P, Ma J, et al
    Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Biomed Pharmacother. 2019;120:109433.
    PubMed     Text format     Abstract available

  5. QUAN Y, Lei H, Wahafu W, Liu Y, et al
    Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Biomed Pharmacother. 2019;120:109490.
    PubMed     Text format     Abstract available


    BJU Int

  6. NURMINEN P, Ettala O, Seppanen M, Taimen P, et al
    Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guerin (BCG) treatment.
    BJU Int. 2019;123:246-251.
    PubMed     Text format     Abstract available

  7. DHARIWAL R, Pindoria N, Dasgupta P, Khan MS, et al
    #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    BJU Int. 2019;123:203-207.
    PubMed     Text format    

  8. KINNEAR N, O'Callaghan M, Hennessey D, Liddell H, et al
    Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
    BJU Int. 2019;123:210-219.
    PubMed     Text format     Abstract available


    BMJ Open

  9. WYLIE H, Cahill F, Santaolalla A, Moss CL, et al
    Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.
    BMJ Open. 2019;9:e029468.
    PubMed     Text format     Abstract available


    Br J Radiol

  10. MAKBOUL M, Farghaly S, Abdelkawi IF
    Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Br J Radiol. 2019 Oct 1:20190401. doi: 10.1259/bjr.20190401.
    PubMed     Text format     Abstract available


    Can J Infect Dis Med Microbiol

  11. TETTEH-QUARCOO PB, Akuetteh BK, Owusu IA, Quayson SE, et al
    Cytological and Wet Mount Microscopic Observations Made in Urine of Schistosoma haematobium-Infected Children: Hint of the Implication in Bladder Cancer.
    Can J Infect Dis Med Microbiol. 2019;2019:7912186.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  12. DI MASO M, Turati F, Bosetti C, Montella M, et al
    Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer.
    Cancer Epidemiol. 2019;63:101595.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  13. WU X, Xu Q, Chen P, Yu C, et al
    Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer.
    Cancer Manag Res. 2019;11:8125-8133.
    PubMed     Text format     Abstract available


    Cancer Med

  14. LIU F, Liu A, Lu X, Zhang Z, et al
    Dysbiosis signatures of the microbial profile in tissue from bladder cancer.
    Cancer Med. 2019 Sep 30. doi: 10.1002/cam4.2419.
    PubMed     Text format     Abstract available


    Chin Med J (Engl)

  15. CHI Q, Wang ZY, Li HY, Song DB, et al
    Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chin Med J (Engl). 2019 Sep 17. doi: 10.1097/CM9.0000000000000455.
    PubMed     Text format     Abstract available


    Clin Exp Med

  16. MAO F, Niu XB, Gu S, Ji L, et al
    The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
    Clin Exp Med. 2019 Oct 1. pii: 10.1007/s10238-019-00582.
    PubMed     Text format     Abstract available


    Curr Urol

  17. SIMON M, Elkayam N, Smerling J, Marcelin M, et al
    Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.
    Curr Urol. 2019;13:54-56.
    PubMed     Text format     Abstract available


    Dis Markers

  18. YANG L, Li YL, Li XQ, Zhang Z, et al
    Corrigendum to "High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer".
    Dis Markers. 2019;2019:5974238.
    PubMed     Text format     Abstract available


    Epidemiology

  19. BARRY KH, Jones RR, Cantor KP, Freeman LEB, et al
    Ingested nitrate and nitrite and bladder cancer in Northern New England.
    Epidemiology. 2019 Sep 30. doi: 10.1097/EDE.0000000000001112.
    PubMed     Text format     Abstract available


    Eur J Cancer Prev

  20. HUANG Y, Wang H, Fu S, Luan T, et al
    Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.
    Eur J Cancer Prev. 2019 Oct 1. doi: 10.1097/CEJ.0000000000000551.
    PubMed     Text format     Abstract available


    Eur Urol

  21. LIU X
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016: Can Patie
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30734.
    PubMed     Text format    

  22. LEOW JJ, Catto JWF, Efstathiou JA, Gore JL, et al
    Quality Indicators for Bladder Cancer Services: A Collaborative Review.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30690.
    PubMed     Text format     Abstract available

  23. KETTUNEN K, Bostrom P, Taimen P
    Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://do
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30731.
    PubMed     Text format    

  24. KRIEGMAIR MC, Rother J, Grychtol B, Theuring M, et al
    Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging.
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30674.
    PubMed     Text format     Abstract available

  25. KAMOUN A, Reynies A, Allory Y, Sjodahl G, et al
    A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30695.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  26. GRIMBERG DC, Shah A, Inman BA
    Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
    Eur Urol Focus. 2019 Sep 24. pii: S2405-4569(19)30282.
    PubMed     Text format     Abstract available


    Genes Genomics

  27. LIAO S, Ou M, Lai L, Lin H, et al
    Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer.
    Genes Genomics. 2019 Oct 1. pii: 10.1007/s13258-019-00868.
    PubMed     Text format     Abstract available


    J Cell Mol Med

  28. LIU X, Zhang X, Bi J, Li Z, et al
    Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.
    J Cell Mol Med. 2019 Sep 29. doi: 10.1111/jcmm.14683.
    PubMed     Text format     Abstract available


    J Clin Med

  29. LIN YH, Hou CP, Juang HH, Chang PL, et al
    Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male.
    J Clin Med. 2019;8.
    PubMed     Text format     Abstract available


    Mol Genet Genomic Med

  30. SHI J, Zhang P, Liu L, Min X, et al
    Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer.
    Mol Genet Genomic Med. 2019 Sep 30:e982. doi: 10.1002.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  31. APOLO AB
    Determining superior first-line therapy in metastatic bladder cancer.
    Nat Rev Urol. 2019 Sep 26. pii: 10.1038/s41585-019-0245.
    PubMed     Text format    


    Onco Targets Ther

  32. HAN N, Yuan F, Xian P, Liu N, et al
    GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
    Onco Targets Ther. 2019;12:7591-7599.
    PubMed     Text format     Abstract available

  33. ZHOU HQ, Liu MS, Deng TB, Xie PB, et al
    The TGF-beta/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.
    Onco Targets Ther. 2019;12:7809-7821.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  34. YANG X, Wang P
    MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
    Pathol Res Pract. 2019 Aug 17:152598. doi: 10.1016/j.prp.2019.152598.
    PubMed     Text format     Abstract available


    Sci Adv

  35. LIU J, Zhang Y, Zeng Q, Zeng H, et al
    Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.
    Sci Adv. 2019;5:eaaw6499.
    PubMed     Text format     Abstract available


    Urol Int

  36. HAUTMANN RE, Bolenz C, Volkmer B
    Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
    Urol Int. 2019 Sep 27:1-6. doi: 10.1159/000503398.
    PubMed     Text format     Abstract available


    Urol Oncol

  37. ALANEE S, Deebajah M, Chen PI, Mora R, et al
    Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.
    Urol Oncol. 2019 Sep 27. pii: S1078-1439(19)30351.
    PubMed     Text format     Abstract available


    Urologiia

  38. ENIKEEV DV, Alyaev YG, Rapoport LM, Taratkin MS, et al
    [Multidisciplinary approach in urology. Laser technologies: faster, simpler, more efficient].
    Urologiia. 2019;.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: